SCHEMBL24614917

SCHEMBL24614917

CC1(C)c2ccc(-c3c4ccccc4c(-c4cc5cc(-c6c7ccccc7c(-c7ccc8c(c7)C(C)(C)C(C)(C)C8(C)C)c7ccccc67)c6oc7ccccc7c6c5c5c4oc4ccccc45)c4ccccc34)cc2C(C)(C)C1(C)C

nearest known ligand 0.31

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
CYP3A4 P08684 1/20 0.31
ALPI P09923 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
HPGD P15428 1/20 0.31
CASP3 P42574 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31
CASP7 P55210 1/20 0.31
CASP6 P55212 1/20 0.31
KMT2A Q03164 1/20 0.31
MCL1 Q07820 1/20 0.31
HSD17B10 Q99714 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ALOX5 P09917 1/20 0.31
CDC14B O60729 2/20 0.30
CDC14A Q9UNH5 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24614739 0.98 CA1 (0.32) KDM4EMEN1CYP3A4ALPIGAA
SCHEMBL24614636 0.94 CA1 (0.30) CA1CA2
SCHEMBL24614797 0.80 CA1 (0.41) KDM4EMEN1CYP3A4ALPIGAA
SCHEMBL24614668 0.80 CA1 (0.43) KDM4EMEN1CYP3A4ALPIGAA
SCHEMBL24614666 0.79 MAOB (0.43) KDM4ECYP3A4MAPTHPGDALOX5
SCHEMBL24614688 0.79 CA1 (0.38) KDM4EMEN1CYP3A4ALPIGAA
SCHEMBL24614658 0.79 GPR84 (0.41) KDM4EMEN1CYP3A4ALPIGAA
SCHEMBL24614815 0.79 CA1 (0.38) KDM4EMEN1CYP3A4ALPIGAA
SCHEMBL24614915 0.79 CDC14B (0.40) KDM4EMEN1CYP3A4ALPIGAA
SCHEMBL24614738 0.78 CDC14B (0.41) KDM4EMEN1CYP3A4ALPIGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES TMEM109, PIEZO1, L1CAM KDM4E 3297/4885MEN1 126/4885CYP3A4 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.